Home > Riviste > Minerva Medica > Fascicoli precedenti > Minerva Medica 2017 October;108(5) > Minerva Medica 2017 October;108(5):479-81

ULTIMO FASCICOLO
 

ARTICLE TOOLS

Publication history
Estratti
Per citare questo articolo

MINERVA MEDICA

Rivista di Medicina Interna


Indexed/Abstracted in: Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,878


eTOC

 

LETTERS TO THE EDITOR  


Minerva Medica 2017 October;108(5):479-81

DOI: 10.23736/S0026-4806.17.05122-9

Copyright © 2017 EDIZIONI MINERVA MEDICA

lingua: Inglese

The clinical significance of neoadjuvant chemotherapy in improving the drug resistance of osteosarcoma

Yongxian WAN 1 , Lili XU 2, Naiqiang ZHUO 1, Jianhua GE 1, Ge CHEN 1, Xiao-Bo LU 1

1 Department of Orthopedics, Affiliated Hospital of Southwest Medical University, Huzhou, China; 2 Department of Rehabilitation Medicine, Affiliated Hospital of Southwest Medical University, Luzhou, China


PDF  


inizio pagina

Publication History

Issue published online: July 21, 2017
Article first published online: May 25, 2017
Manuscript accepted: May 4, 2017
Manuscript revised: April 19, 2017
Manuscript received: February 26, 2017

Per citare questo articolo

Wan Y, Xu L, Zhuo N, Ge J, Chen G, Lu XB. The clinical significance of neoadjuvant chemotherapy in improving the drug resistance of osteosarcoma. Minerva Med 2017;108:479-81. DOI: 10.23736/S0026-4806.17.05122-9

Corresponding author e-mail

Wanyongxian2016@163.com